1.24
price up icon5.08%   0.06
pre-market  시장 영업 전:  1.24  
loading

Alx Oncology Holdings Inc (ALXO) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
16.25%
26.65
31.82 30.61 32.57 41.52
Interest Income/Expense
0.25%
0.405
0.406 0.427 0.446 0.429
Depreciation and Amortization
0.00%
0.20
0.20 0.20 0.20 0.20
Operating Income/Loss
16.25%
-26.65
-31.82 -30.61 -32.57 -41.52
Income/Loss From Continuing Operations Before Tax
15.62%
-25.95
-30.75 -29.16 -30.71 -39.40
Income/Loss From Continuing Operations After Tax
15.62%
-25.95
-30.75 -29.16 -30.71 -39.40
Net Income/Loss
15.62%
-25.95
-30.75 -29.16 -30.71 -39.40
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.16%
53.45
53.36 0.6304 52.69 51.83
Diluted Average Shares
0.16%
53.45
53.36 0.6304 52.69 51.83
Basic Earnings Per Share
15.52%
-0.49
-0.58 -0.53 -0.58 -0.76
Diluted Earnings Per Share
15.52%
-0.49
-0.58 -0.53 -0.58 -0.76
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$33.63
price down icon 0.80%
$107.39
price up icon 4.56%
$105.92
price down icon 4.21%
$98.85
price down icon 1.23%
biotechnology ONC
$320.37
price down icon 4.04%
$170.27
price down icon 3.26%
자본화:     |  볼륨(24시간):